← Back to headlines
Rocket Pharmaceuticals, Compass Therapeutics Report Q1 Net Losses
Rocket Pharmaceuticals reported a Q1 2026 net loss of $47.6 million, while Compass Therapeutics also announced a net loss of $18.3 million for the same quarter. Both pharmaceutical companies disclosed their financial results.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
